Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
The report details the trend, potential and market size of Somatostatin Analogs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Somatostatin Analogsmarket, defines the market attractiveness level of Somatostatin Analogs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Somatostatin Analogs industry, describes the types of Somatostatin Analogs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Somatostatin Analogs market and the development prospects and opportunities of Somatostatin Analogs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Somatostatin Analogs market in Chapter 13.
By Player:
Novartis
Chiasma
Peptron
Ipsen Biopharmaceutical
By Type:
Octreotide
Lanreotide
Pasireotide
By End-User:
Acromegaly
Carcinoid Syndrome
Neuroendocrine Tumor
Cushing Syndrome
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Somatostatin Analogs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Somatostatin Analogs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Somatostatin Analogs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Somatostatin Analogs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Somatostatin Analogs Market Analysis and Outlook to 2022
-
7.1 Global Somatostatin Analogs Consumption (2017-2022)
-
7.2 United States Somatostatin Analogs Consumption (2017-2022)
-
7.3 Europe Somatostatin Analogs Consumption (2017-2022)
-
7.4 China Somatostatin Analogs Consumption (2017-2022)
-
7.5 Japan Somatostatin Analogs Consumption (2017-2022)
-
7.6 India Somatostatin Analogs Consumption (2017-2022)
-
7.7 South Korea Somatostatin Analogs Consumption (2017-2022)
8 Region and Country-wise Somatostatin Analogs Market Analysis and Outlook to 2028
-
8.1 Global Somatostatin Analogs Consumption Forecast (2022-2028)
-
8.2 United States Somatostatin Analogs Consumption Forecast (2022-2028)
-
8.3 Europe Somatostatin Analogs Consumption Forecast (2022-2028)
-
8.4 China Somatostatin Analogs Consumption Forecast (2022-2028)
-
8.5 Japan Somatostatin Analogs Consumption Forecast (2022-2028)
-
8.6 India Somatostatin Analogs Consumption Forecast (2022-2028)
-
8.7 South Korea Somatostatin Analogs Consumption Forecast (2022-2028)
9 Global Somatostatin Analogs Market Outlook by Types and Applications to 2022
-
9.1 Global Somatostatin Analogs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Octreotide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lanreotide Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pasireotide Consumption and Growth Rate (2017-2022)
-
9.2 Global Somatostatin Analogs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acromegaly Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Carcinoid Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neuroendocrine Tumor Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cushing Syndrome Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Somatostatin Analogs Market Outlook by Types and Applications to 2028
-
10.1 Global Somatostatin Analogs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Lanreotide Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pasireotide Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Somatostatin Analogs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Carcinoid Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neuroendocrine Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cushing Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Somatostatin Analogs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Somatostatin Analogs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Somatostatin Analogs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Somatostatin Analogs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Somatostatin Analogs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Somatostatin Analogs Product and Service
-
14.2 Chiasma
-
14.2.1 Chiasma Company Details
-
14.2.2 Chiasma Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Chiasma Somatostatin Analogs Product and Service
-
14.3 Peptron
-
14.3.1 Peptron Company Details
-
14.3.2 Peptron Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Peptron Somatostatin Analogs Product and Service
-
14.4 Ipsen Biopharmaceutical
-
14.4.1 Ipsen Biopharmaceutical Company Details
-
14.4.2 Ipsen Biopharmaceutical Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Ipsen Biopharmaceutical Somatostatin Analogs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Somatostatin Analogs
-
Figure Somatostatin Analogs Picture
-
Table Global Somatostatin Analogs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Somatostatin Analogs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Somatostatin Analogs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Somatostatin Analogs Consumption by Country (2017-2022)
-
Figure United States Somatostatin Analogs Consumption and Growth Rate (2017-2022)
-
Table Europe Somatostatin Analogs Consumption and Growth Rate (2017-2022)
-
Figure China Somatostatin Analogs Consumption and Growth Rate (2017-2022)
-
Figure Japan Somatostatin Analogs Consumption and Growth Rate (2017-2022)
-
Figure India Somatostatin Analogs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Somatostatin Analogs Consumption and Growth Rate (2017-2022)
-
Figure Global Somatostatin Analogs Consumption Forecast by Country (2022-2028)
-
Figure United States Somatostatin Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Somatostatin Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Somatostatin Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Somatostatin Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Somatostatin Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Somatostatin Analogs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Octreotide Consumption and Growth Rate (2017-2022)
-
Figure Global Lanreotide Consumption and Growth Rate (2017-2022)
-
Figure Global Pasireotide Consumption and Growth Rate (2017-2022)
-
Figure Global Acromegaly Consumption and Growth Rate (2017-2022)
-
Figure Global Carcinoid Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Neuroendocrine Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Cushing Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Octreotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lanreotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pasireotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acromegaly Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carcinoid Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neuroendocrine Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cushing Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Somatostatin Analogs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Somatostatin Analogs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Somatostatin Analogs Product and Service
-
Table Chiasma (Foundation Year, Company Profile and etc.)
-
Table Chiasma Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chiasma Somatostatin Analogs Product and Service
-
Table Peptron (Foundation Year, Company Profile and etc.)
-
Table Peptron Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Peptron Somatostatin Analogs Product and Service
-
Table Ipsen Biopharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Ipsen Biopharmaceutical Somatostatin Analogs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Biopharmaceutical Somatostatin Analogs Product and Service
-
